Agency Forms Undergoing Paperwork Reduction Act Review, 4468-4469 [2019-02496]
Download as PDF
<![CDATA[
4468
Federal Register / Vol. 84, No. 32 / Friday, February 15, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Employers .......................................................
CDC Worksite Health ScoreCard Registration.
CDC Worksite Health Scorecard ...................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–02497 Filed 2–14–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–0338]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKBBV9HB2PROD with NOTICES
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Annual
Submission of the Ingredients Added to,
and the Quantity of Nicotine Contained
in, Smokeless Tobacco Manufactured,
Imported, or Packaged in the U.S. to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on August 22, 2018 to obtain
comments from the public and affected
agencies. CDC received two comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
19:41 Feb 14, 2019
Jkt 247001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Annual Submission of the Ingredients
Added to, and the Quantity of Nicotine
Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in
the U.S. (OMB No. 0920–0338 exp. 12/
31/2018)—Reinstatement without
Change—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are
associated with many health problems.
Using smokeless tobacco: Can lead to
nicotine addiction; causes cancer of the
mouth, esophagus, and pancreas; is
associated with diseases of the mouth;
can increase risks for early delivery and
stillbirth when used during pregnancy;
can cause nicotine poisoning in
children; and may increase the risk for
death from heart disease and stroke.
The CDC’s Office on Smoking and
Health (OSH) has the primary
responsibility for the HHS smoking and
health program. As required by the
Comprehensive Smokeless Tobacco
Health Education Act of 1986 (CSTHEA,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hrs)
800
1
5/60
800
1
45/60
15 U.S.C. 4401 et seq., Pub. L. 99–252),
CDC collects a list of ingredients added
to tobacco in the manufacture of
smokeless tobacco products and a
specification of the quantity of nicotine
contained in each product. HHS has
delegated responsibility for
implementing the required information
collection to CDC’s OSH. Respondents
are manufacturers, packagers, or
importers (or their representatives) of
smokeless tobacco products.
Respondents are not required to submit
specific forms; however, they are
required to meet reporting guidelines
and to submit the ingredient report by
chemical name and Chemical Abstract
Service (CAS) Registration Number,
consistent with accepted reporting
practices for other companies that are
required to report ingredients added to
other consumer products. Typically,
respondents submit a summary report to
CDC with the ingredient information for
multiple products, or a statement that
there are no changes to their previously
submitted ingredient report.
Respondents may submit the required
information to CDC through a
designated representative. The
information collection is subject to strict
confidentiality provisions.
Ingredient reports for new SLT
products are due at the time of first
importation. Thereafter, ingredient
reports are due annually on March 31.
Information is submitted to CDC by
mailing a written report on the
respondent’s letterhead, by CD, threeinch floppy disk, or thumb drive.
Electronic mail submissions are not
accepted. Annual submission reports
are mailed to Attention: FCLAA
Program Manager, Office on Smoking
and Health, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway
NE, MS S107–7, Atlanta, GA 30341–
3717.
Upon receipt and verification of the
annual nicotine and ingredient report,
CDC issues a Certificate of Compliance
to the respondent. As deemed
appropriate by the Secretary of HHS,
HHS is authorized to use the
information to report to Congress the
E:\FR\FM\15FEN1.SGM
15FEN1
4469
Federal Register / Vol. 84, No. 32 / Friday, February 15, 2019 / Notices
health effects of ingredients, research
activities related to the health effects of
ingredients, and other information that
the Secretary determines to be of public
interest.
There are no costs to respondents
other than their time. OMB approval is
requested for three years.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Smokeless Tobacco Manufacturers, Packagers, and Importers.
SLT Nicotine and Ingredient and Report .......
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–02496 Filed 2–14–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–18FJ]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKBBV9HB2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Evaluation of
the Chronic Disease Self-Management
Program in the US Affiliated Pacific
Islands to the Office of Management and
Budget (OMB) for review and approval.
CDC previously published a ‘‘Proposed
Data Collection Submitted for Public
Comment and Recommendations’’
notice on February 2, 2018 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
VerDate Sep<11>2014
19:41 Feb 14, 2019
Jkt 247001
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Evaluation of the Chronic Disease
Self-Management Program in the US
Affiliated Pacific Islands—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
NCCDPHP plans to evaluate the first
ever implementation of Stanford
University’s Chronic Disease SelfManagement Program (CDSMP) in the
US Affiliated Pacific Islands (USAPIs).
CDSMP is a 6-week series of workshops
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
11
Number of
responses per
respondent
1
Average
burden per
response
(in hours)
1,713
for people with arthritis, diabetes, lung
disease, cancer, and other health
problems. The workshops focus on
helping participants learn strategies to
manage chronic disease, including
techniques to deal with problems such
as frustration, fatigue, pain and
isolation; appropriate exercise for
maintaining and improving strength,
flexibility, and endurance; and
appropriate use of medications among
others. Proven benefits of CDSMP
include decreased pain and health
distress, increased energy and fatigue,
increased physical activity, better
communication with health care
providers, and increased confidence in
managing chronic disease.
The program will be offered
repeatedly over the course of three
years, which will cover repeated data
collections in the USAPIs. These
jurisdictions include American Samoa,
Guam, the Commonwealth of the
Northern Mariana Islands, the Republic
of Palau, the Republic of the Marshall
Islands, and the Federated States of
Micronesia. Because this is the first time
CDSMP is being implemented in the
USAPIs, we do not know if the
intervention, which has proven to
improve health outcomes in many
ethnic groups within the United States,
will lead to improved health outcomes
for these communities.
The purpose of the evaluation is to
understand how CDSMP is being
implemented in the region, to identify
barriers and facilitators to
implementation, to monitor fidelity to
Stanford University’s model and
document adaptations to the
curriculum, and to understand the selfreported effects of the program on
program participants. The estimated
annual burden hours are 95. There are
no costs to respondents other than their
time.
E:\FR\FM\15FEN1.SGM
15FEN1
]]>Agencies
[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Pages 4468-4469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02496]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-0338]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Annual Submission of the Ingredients Added
to, and the Quantity of Nicotine Contained in, Smokeless Tobacco
Manufactured, Imported, or Packaged in the U.S. to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on August 22, 2018 to obtain comments from the
public and affected agencies. CDC received two comments related to the
previous notice. This notice serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Annual Submission of the Ingredients Added to, and the Quantity of
Nicotine Contained in, Smokeless Tobacco Manufactured, Imported, or
Packaged in the U.S. (OMB No. 0920-0338 exp. 12/31/2018)--Reinstatement
without Change--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Smokeless tobacco products (SLT) are associated with many health
problems. Using smokeless tobacco: Can lead to nicotine addiction;
causes cancer of the mouth, esophagus, and pancreas; is associated with
diseases of the mouth; can increase risks for early delivery and
stillbirth when used during pregnancy; can cause nicotine poisoning in
children; and may increase the risk for death from heart disease and
stroke.
The CDC's Office on Smoking and Health (OSH) has the primary
responsibility for the HHS smoking and health program. As required by
the Comprehensive Smokeless Tobacco Health Education Act of 1986
(CSTHEA, 15 U.S.C. 4401 et seq., Pub. L. 99-252), CDC collects a list
of ingredients added to tobacco in the manufacture of smokeless tobacco
products and a specification of the quantity of nicotine contained in
each product. HHS has delegated responsibility for implementing the
required information collection to CDC's OSH. Respondents are
manufacturers, packagers, or importers (or their representatives) of
smokeless tobacco products. Respondents are not required to submit
specific forms; however, they are required to meet reporting guidelines
and to submit the ingredient report by chemical name and Chemical
Abstract Service (CAS) Registration Number, consistent with accepted
reporting practices for other companies that are required to report
ingredients added to other consumer products. Typically, respondents
submit a summary report to CDC with the ingredient information for
multiple products, or a statement that there are no changes to their
previously submitted ingredient report. Respondents may submit the
required information to CDC through a designated representative. The
information collection is subject to strict confidentiality provisions.
Ingredient reports for new SLT products are due at the time of
first importation. Thereafter, ingredient reports are due annually on
March 31. Information is submitted to CDC by mailing a written report
on the respondent's letterhead, by CD, three-inch floppy disk, or thumb
drive. Electronic mail submissions are not accepted. Annual submission
reports are mailed to Attention: FCLAA Program Manager, Office on
Smoking and Health, National Center for Chronic Disease Prevention and
Health Promotion, Centers for Disease Control and Prevention, 4770
Buford Highway NE, MS S107-7, Atlanta, GA 30341-3717.
Upon receipt and verification of the annual nicotine and ingredient
report, CDC issues a Certificate of Compliance to the respondent. As
deemed appropriate by the Secretary of HHS, HHS is authorized to use
the information to report to Congress the
[[Page 4469]]
health effects of ingredients, research activities related to the
health effects of ingredients, and other information that the Secretary
determines to be of public interest.
There are no costs to respondents other than their time. OMB
approval is requested for three years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Smokeless Tobacco Manufacturers, SLT Nicotine and 11 1 1,713
Packagers, and Importers. Ingredient and Report.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-02496 Filed 2-14-19; 8:45 am]
BILLING CODE 4163-18-P
